Exploring the Immunology of Sarcoidosis
NCT04637165 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9
Last updated 2024-10-02
Summary
In sarcoidosis, over activity of parts of the immune system drives the accumulation of granulomas (collections of immune cells) in affected parts of the body. To facilitate development of effective and safe treatment options in the future it will be vital to understand how and why the immune system becomes over active. The aim of this research is to work towards this goal by studying cells of the immune system and the molecular pathways inside these cells that control how they behave. This will be achieved by analysing patterns of proteins and RNA (the code used to tell cells which proteins to produce) in immune cells present in blood samples and tissue biopsies from people with sarcoidosis.
Conditions
- Sarcoidosis
Interventions
- OTHER
-
This is a non-interventional study
This is a non-interventional study
Sponsors & Collaborators
-
University of York
collaborator OTHER -
Hull University Teaching Hospitals NHS Trust
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-11
- Primary Completion
- 2022-12-31
- Completion
- 2023-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis
NCT00282438 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare
NCT03910543 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis
NCT00955279 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
NCT05890729 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis
NCT00690911 ·Status: WITHDRAWN ·Phase: PHASE2
-
Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis
NCT03793439 ·Status: COMPLETED ·Phase: PHASE1
-
Janus Kinase Inhibition in Sarcoidosis
NCT05696795 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Controlled Trial of Hydroxychloroquine Combined With Low-dose Corticosteroid in Pulmonary Sarcoidosis
NCT05247554 ·Status: UNKNOWN ·Phase: PHASE3
-
Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995
NCT02116764 ·Status: COMPLETED
-
A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis
NCT05314517 ·Status: TERMINATED ·Phase: PHASE2
-
Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis
NCT04008069 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications
NCT05104723 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phenotypic and Functional Characterisation of Human B-cell Response in Pemphigus
NCT04117529 ·Status: UNKNOWN ·Phase: NA
-
An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies
NCT00072592 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
NCT06169397 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Treatment of CNS Sarcoidosis With H.P. Acthar Gel
NCT02298491 ·Status: COMPLETED ·Phase: PHASE4
-
Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis
NCT04017936 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
NCT06716606 ·Status: RECRUITING ·Phase: PHASE3
-
Bronchial Inflammation in Patients With Severe Immune Deficiency Under Immunoglobulin Treatment
NCT01359384 ·Status: UNKNOWN
-
Study of Mast Cell Precursors
NCT00001756 ·Status: COMPLETED
-
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
NCT06205121 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Infliximab in Patients With Sarcoidosis
NCT00073437 ·Status: COMPLETED ·Phase: PHASE3
-
Ocular Sarcoidosis Open Label Trial of ACTHAR Gel
NCT02725177 ·Status: COMPLETED ·Phase: NA
-
Safety and Clinical Activity of Itolizumab in aGVHD
NCT05823675 ·Status: UNKNOWN ·Phase: PHASE1
-
Role of Interferon-gamma 1-b (IFN-γ) on Cells of the Innate Immune System: Functional, Biochemical and Gene Expression Studies in Patients With Chronic Granulomatous Disease
NCT03548818 ·Status: COMPLETED